FAQ: Blood Clotting in IBD Patients - New Research Findings

What is the main topic of this research?

The research explains why blood clotting is common in patients with irritable bowel disease (IBD) and suggests a possible way to address this problem while also reducing inflammation.

How many people in the U.S. are affected by IBD?

Approximately 3 million people in the U.S. live with irritable bowel disease, and its prevalence is rising.

Why is blood clotting in IBD patients concerning?

Blood clots in IBD patients can result in serious complications including strokes and heart attacks.

Who conducted this research study?

The research was conducted by Utah University, as mentioned in the content.

What potential benefit does this research offer?

The research offers hope that meaningful treatments for IBD can be developed using the findings, potentially addressing both blood clotting and inflammation.

Are there companies working on IBD treatments mentioned in the article?

Yes, the article mentions that many firms like Soligenix Inc. (NASDAQ: SNGX) are engaged in efforts to develop treatments for IBD.

Where can I read more about this study?

You can read more about the study on the BioMedWire website.

Is there a cure for IBD currently available?

No, according to the content, there isn’t a cure for irritable bowel disease at the moment.

What organization published this information?

This information was published by BioMedWire, a specialized communications platform focused on biotechnology, biomedical sciences, and life sciences sectors.